# PROLIFICA - West African Treatment Cohort for Hepatitis B

> **NCT02129829** · — · COMPLETED · sponsor: **Imperial College London** · enrollment: 1079 (actual)

## Conditions studied

- Hepatitis B, Chronic
- Hepatocellular Carcinoma

## Interventions

- **DRUG:** Tenofovir disoproxil

## Key facts

- **NCT ID:** NCT02129829
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2018-07-31
- **Final completion:** 2018-07-31
- **Target enrollment:** 1079 (ACTUAL)
- **Last updated:** 2020-09-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02129829

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02129829, "PROLIFICA - West African Treatment Cohort for Hepatitis B". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02129829. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*